Metamark Genetics names Straley as CEO
Molecular diagnostics startup Metamark Genetics Inc. has named Mark Straley as the company’s new president, CEO and member of the board of directors. Interim CEO Kenneth Weg, a co-founder of the company, will continue in his role as chairman of the board.
Straley’s experience in diagnostics and diabetes stems from a previous role as worldwide president of Johnson & Johnson’s Diagnostics division, where he began working in 2005 as vice president of marketing. He gained prior management, sales and marketing experience at Bayer Healthcare and Abbott Laboratories. Straley earned a bachelor’s degree from Miami University of Ohio.